Literature DB >> 29127268

Sickle Mice Are Sensitive to Hypoxia/Ischemia-Induced Stroke but Respond to Tissue-Type Plasminogen Activator Treatment.

Yu-Yo Sun1, Jolly Lee1, Henry Huang1, Mary B Wagner1, Clinton H Joiner1, David R Archer1, Chia-Yi Kuan2.   

Abstract

BACKGROUND AND
PURPOSE: The effects of lytic stroke therapy in patients with sickle cell anemia are unknown, although a recent study suggested that coexistent sickle cell anemia does not increase the risk of cerebral hemorrhage. This finding calls for systemic analysis of the effects of thrombolytic stroke therapy, first in humanized sickle mice, and then in patients. There is also a need for additional predictive markers of sickle cell anemia-associated vasculopathy.
METHODS: We used Doppler ultrasound to examine the carotid artery of Townes sickle mice tested their responses to repetitive mild hypoxia-ischemia- and transient hypoxia-ischemia-induced stroke at 3 or 6 months of age, respectively. We also examined the effects of tPA (tissue-type plasminogen activator) treatment in transient hypoxia-ischemia-injured sickle mice.
RESULTS: Three-month-old sickle cell (SS) mice showed elevated resistive index in the carotid artery and higher sensitivity to repetitive mild hypoxia-ischemia-induced cerebral infarct. Six-month-old SS mice showed greater resistive index and increased flow velocity without obstructive vasculopathy in the carotid artery. Instead, the cerebral vascular wall in SS mice showed ectopic expression of PAI-1 (plasminogen activator inhibitor-1) and P-selectin, suggesting a proadhesive and prothrombotic propensity. Indeed, SS mice showed enhanced leukocyte and platelet adherence to the cerebral vascular wall, broader fibrin deposition, and higher mortality after transient hypoxia-ischemia. Yet, post-transient hypoxia-ischemia treatment with tPA reduced thrombosis and mortality in SS mice.
CONCLUSIONS: Sickle mice are sensitive to hypoxia/ischemia-induced cerebral infarct but benefit from thrombolytic treatment. An increased resistive index in carotid arteries may be an early marker of sickle cell vasculopathy.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  anemia, sickle cell; blood platelets; cerebral infarction; fibrin; stroke; tissue-type plasminogen activator; ultrasonography, Doppler

Mesh:

Substances:

Year:  2017        PMID: 29127268      PMCID: PMC5726594          DOI: 10.1161/STROKEAHA.117.018334

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  30 in total

1.  Correction of sickle cell disease by homologous recombination in embryonic stem cells.

Authors:  Li-Chen Wu; Chiao-Wang Sun; Thomas M Ryan; Kevin M Pawlik; Jinxiang Ren; Tim M Townes
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

Review 2.  Microvascular rheology and hemodynamics.

Authors:  Herbert H Lipowsky
Journal:  Microcirculation       Date:  2005 Jan-Feb       Impact factor: 2.628

3.  Placenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD).

Authors:  Nitin Patel; Nambirajan Sundaram; Mingyan Yang; Catherine Madigan; Vijay K Kalra; Punam Malik
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

4.  Renal Doppler indices in sickle cell disease: early radiologic predictors of renovascular changes.

Authors:  Kishor B Taori; Ritu S Chaudhary; Vinod Attarde; Suresh Dhakate; Virender Sheorain; Prashant Nimbalkar; Preetam N Wasnik
Journal:  AJR Am J Roentgenol       Date:  2008-07       Impact factor: 3.959

5.  Mannitol-facilitated perfusion staining with 2,3,5-triphenyltetrazolium chloride (TTC) for detection of experimental cerebral infarction and biochemical analysis.

Authors:  Yu-Yo Sun; Dianer Yang; Chia-Yi Kuan
Journal:  J Neurosci Methods       Date:  2011-10-01       Impact factor: 2.390

6.  Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

Authors:  Michael R DeBaun; Mae Gordon; Robert C McKinstry; Michael J Noetzel; Desiree A White; Sharada A Sarnaik; Emily R Meier; Thomas H Howard; Suvankar Majumdar; Baba P D Inusa; Paul T Telfer; Melanie Kirby-Allen; Timothy L McCavit; Annie Kamdem; Gladstone Airewele; Gerald M Woods; Brian Berman; Julie A Panepinto; Beng R Fuh; Janet L Kwiatkowski; Allison A King; Jason M Fixler; Melissa M Rhodes; Alexis A Thompson; Mark E Heiny; Rupa C Redding-Lallinger; Fenella J Kirkham; Natalia Dixon; Corina E Gonzalez; Karen A Kalinyak; Charles T Quinn; John J Strouse; J Philip Miller; Harold Lehmann; Michael A Kraut; William S Ball; Deborah Hirtz; James F Casella
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

7.  Large cerebral vessel disease in sickle cell anaemia.

Authors:  L Boros; C Thomas; W J Weiner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-12       Impact factor: 10.154

8.  A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia.

Authors:  Yu-Yo Sun; Chia-Yi Kuan
Journal:  J Vis Exp       Date:  2015-08-18       Impact factor: 1.355

9.  Hemodynamic etiology of elevated flow velocity and stroke in sickle-cell disease.

Authors:  Isak Prohovnik; Anne Hurlet-Jensen; Robert Adams; Darryl De Vivo; Steven G Pavlakis
Journal:  J Cereb Blood Flow Metab       Date:  2009-02-11       Impact factor: 6.200

10.  Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial.

Authors:  Kathleen J Helton; Robert J Adams; Karen L Kesler; Alex Lockhart; Banu Aygun; Catherine Driscoll; Matthew M Heeney; Sherron M Jackson; Lakshmanan Krishnamurti; Scott T Miller; Sharada A Sarnaik; William H Schultz; Russell E Ware
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

View more
  5 in total

Review 1.  The multifaceted role of ischemia/reperfusion in sickle cell anemia.

Authors:  Robert P Hebbel; John D Belcher; Gregory M Vercellotti
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

2.  Renal protection by atorvastatin in a murine model of sickle cell nephropathy.

Authors:  Rima S Zahr; Prasanthi Chappa; Hong Yin; Lou A Brown; Kenneth I Ataga; David R Archer
Journal:  Br J Haematol       Date:  2018-03-12       Impact factor: 6.998

3.  A murine photothrombotic stroke model with an increased fibrin content and improved responses to tPA-lytic treatment.

Authors:  Yu-Yo Sun; Yi-Min Kuo; Hong-Ru Chen; Jonah C Short-Miller; Marchelle R Smucker; Chia-Yi Kuan
Journal:  Blood Adv       Date:  2020-04-14

4.  Age-dependent characterization of carotid and cerebral artery geometries in a transgenic mouse model of sickle cell anemia using ultrasound and microcomputed tomography.

Authors:  Christian P Rivera; Li Li; Shuangyi Cai; Nui Pei; George E McAlear; Keval Bollavaram; Oluwasanmi V Ariyo; Victor O Omojola; Hannah Song; Andrea L Alfonso; Wenchang Tan; Yunlong Huo; Manu O Platt
Journal:  Blood Cells Mol Dis       Date:  2020-08-13       Impact factor: 3.039

5.  Thousand and one kinase 1 protects MCAO-induced cerebral ischemic stroke in rats by decreasing apoptosis and pro-inflammatory factors.

Authors:  Jiahui Li; Zhijie Liu; Liling Wang; Haiyan Xu; Yulin Wang
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.